Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does cause nausea, vomiting and other gut-related side effects in a significant number of people, particularly during the first few weeks or after a dose increase. These effects are real, but for most people they are manageable, tend to ease within days to a couple of weeks, and rarely mean treatment needs to stop. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber reviews your full health picture before any treatment begins, and that clinical relationship is your best resource when side effects arrive.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) slows the rate at which your stomach empties its contents into the small intestine. That mechanism is central to how the medicine reduces appetite, but it is also exactly why nausea is so common early on. Your gut is adapting to a new rhythm, and the adjustment period is uncomfortable for many people.
The treatment schedule is designed with this in mind. The starting dose of 2.5mg exists specifically to let your system settle, it is not a therapeutic weight-loss dose so much as a tolerance-building one. Prescribers titrate slowly, typically in four-week steps, for the same reason: giving the body time to adjust before the dose rises again. Most people find the worst of the nausea clears within one to two weeks of each new level, then recedes to something manageable or absent altogether.
The NHS medicines guidance on tirzepatide confirms that nausea, vomiting, diarrhoea, constipation, indigestion and burping are all recognised common side effects, and that they generally improve over time. Fatigue, headache and dizziness also appear in the side-effect profile, though these are less frequently the main complaint.
A question our prescribers hear most weeks is whether there is anything concrete someone can do to reduce the nausea, or whether they just have to wait it out. The honest answer is: a bit of both, but the practical adjustments are genuinely worth trying.
Eating smaller portions and stopping before you feel full works with the medicine rather than against it. Fatty, rich or spicy foods tend to sit heavily in a slower-emptying stomach, so many people find they trigger more discomfort during the early weeks. Eating slowly and remaining upright for a while afterwards can help. Staying well hydrated matters especially if vomiting or diarrhoea is present, dehydration on top of GI upset can become a problem in its own right.
If nausea is your main difficulty, you might find it useful to read how others manage ongoing nausea on Mounjaro and what the clinical evidence says about persistence rates. Cold or room-temperature food is sometimes better tolerated than hot meals. Avoiding lying down straight after eating is a simple step that makes a real difference for some people.
None of these adjustments replace your prescriber's guidance. If side effects are severe or significantly affecting your daily life, that is a clinical conversation, not one to push through alone.
Most Mounjaro-related sickness is unpleasant but not dangerous. Some symptoms, though, are signals to get help quickly rather than waiting to see if they settle.
Severe stomach pain that persists and radiates towards the back (with or without vomiting) should prompt urgent medical assessment. In January 2026 the MHRA issued a Drug Safety Update for GLP-1 medicines highlighting acute pancreatitis as an infrequent but serious known risk. The key word is severe: ordinary nausea does not behave this way, and distinguishing the two matters.
Signs of significant dehydration from repeated vomiting or diarrhoea (very dark urine, dizziness on standing, inability to keep any fluids down) also warrant prompt attention, as they can affect kidney function. Gallbladder symptoms (sharp pain in the upper-right abdomen, sometimes after eating) are another side effect to flag to a clinician rather than manage at home.
You can also report any suspected side effect directly via the MHRA Yellow Card scheme, the regulator uses these reports to monitor medicines in real-world use, and Mounjaro carries a Black Triangle (▼) status reflecting its ongoing safety monitoring. If you have broader questions about whether Mounjaro can make you sick and why it happens, that page covers the complete picture in detail.
For a small number of people, side effects do not ease as expected and the right clinical response is to slow the titration, hold at the current dose for longer, or in some cases reconsider the treatment. That is a legitimate outcome, not a failure. The goal is sustainable treatment, not speed.
This is precisely why the clinical relationship matters throughout, not only at the start. At nume, a prescriber reviews your case before every repeat, and if you are feeling unwell on Mounjaro between doses, that review is the moment to raise it, not an afterthought. There is no algorithm deciding whether to continue your treatment. A real clinician reads your update.
If cost is on your mind as well as tolerability, it is worth knowing that how private Mounjaro is priced in the UK varies by provider and dose, and that what any headline price actually includes differs considerably. Aftercare and prescriber access are not always part of the deal, worth checking before you commit.
For anyone considering treatment or already on it and struggling, our free consultation gives you direct access to a prescriber who can review your situation properly. If you are still weighing up whether Mounjaro is likely to make you feel sick, that page sets out what the evidence shows before you decide. Check your eligibility and talk to our team, that is what they are there for.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.